Favipiravir, lopinavir-ritonavir, or combination therapy (FLARE): A randomised, double-blind, 2 × 2 factorial placebo-controlled trial of early antiviral therapy in COVID-19.
David M LoweLi-An K BrownKashfia ChowdhuryStephanie DaveyPhilip YeeFelicia IkejiAmalia NdoutoumouDivya ShahAlexander LennonAbhulya RaiAkosua A AgyemanAnna CheckleyNicola LongleyHakim-Moulay DehbiNick FreemantleJuanita PangJoseph F Standingnull nullPublished in: PLoS medicine (2022)
Clinicaltrials.gov NCT04499677 EudraCT: 2020-002106-68.